Provident Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.08M | Sell |
5,750
-430
| -7% | -$147K | 0.2% | 31 |
|
|
2026
Q1 | $2.17M | Buy |
6,180
+625
| +11% | +$223K | 0.22% | 29 |
|
|
2025
Q4 | $1.82M | Buy |
5,555
+885
| +19% | +$281K | 0.17% | 30 |
|
|
2025
Q3 | $1.32M | Buy |
4,670
+65
| +1% | +$18.9K | 0.12% | 35 |
|
|
2025
Q2 | $1.29M | Buy |
+4,605
| New | +$1.3M | 0.11% | 32 |
|
|
2021
Q4 | – | Sell |
-1,148
| Closed | -$244K | – | 60 |
|
|
2021
Q3 | $244K | Buy |
+1,148
| New | +$264K | 0.02% | 56 |
|
|
2020
Q1 | – | Sell |
-1,200
| Closed | -$289K | – | 49 |
|
|
2019
Q4 | $289K | Hold |
1,200
| – | – | 0.04% | 46 |
|
|
2019
Q3 | $232K | Hold |
1,200
| – | – | 0.03% | 51 |
|
|
2019
Q2 | $221K | Hold |
1,200
| – | – | 0.03% | 54 |
|
|
2019
Q1 | $228K | Hold |
1,200
| – | – | 0.04% | 52 |
|
|
2018
Q4 | $234K | Sell |
1,200
-6,000
| -83% | -$1.17M | 0.04% | 53 |
|
|
2018
Q3 | $1.49M | Sell |
7,200
-6,000
| -45% | -$1.18M | 0.21% | 33 |
|
|
2018
Q2 | $2.44M | Buy |
13,200
+6,000
| +83% | +$1.06M | 0.35% | 30 |
|
|
2018
Q1 | $1.23M | Sell |
7,200
-450
| -6% | -$82.6K | 0.19% | 32 |
|
|
2017
Q4 | $1.33M | Hold |
7,650
| – | – | 0.21% | 31 |
|
|
2017
Q3 | $1.43M | Hold |
7,650
| – | – | 0.24% | 30 |
|
|
2017
Q2 | $1.32M | Hold |
7,650
| – | – | 0.24% | 29 |
|
|
2017
Q1 | $1.25M | Hold |
7,650
| – | – | 0.23% | 31 |
|
|
2016
Q4 | $1.12M | Hold |
7,650
| – | – | 0.22% | 31 |
|
|
2016
Q3 | $1.28M | Hold |
7,650
| – | – | 0.26% | 30 |
|
|
2016
Q2 | $1.16M | Hold |
7,650
| – | – | 0.24% | 32 |
|
|
2016
Q1 | $1.15M | Hold |
7,650
| – | – | 0.23% | 29 |
|
|
2015
Q4 | $1.24M | Hold |
7,650
| – | – | 0.25% | 30 |
|
|
2015
Q3 | $1.06M | Hold |
7,650
| – | – | 0.22% | 30 |
|
|
2015
Q2 | $1.17M | Hold |
7,650
| – | – | 0.23% | 30 |
|
|
2015
Q1 | $1.22M | Sell |
7,650
-1,713
| -18% | -$270K | 0.25% | 29 |
|
|
2014
Q4 | $1.49M | Hold |
9,363
| – | – | 0.32% | 25 |
|
|
2014
Q3 | $1.31M | Hold |
9,363
| – | – | 0.31% | 27 |
|
|
2014
Q2 | $1.11M | Sell |
9,363
-1,887
| -17% | -$218K | 0.26% | 28 |
|
|
2014
Q1 | $1.39M | Sell |
11,250
-125
| -1% | -$15.2K | 0.34% | 26 |
|
|
2013
Q4 | $1.3M | Sell |
11,375
-2,400
| -17% | -$273K | 0.33% | 28 |
|
|
2013
Q3 | $1.54M | Buy |
13,775
+50
| +0.4% | +$5.42K | 0.42% | 24 |
|
|
2013
Q2 | $1.35M | Buy |
+13,725
| New | +$1.42M | 0.4% | 25 |
|
Other funds holding AMGN
Provident Investment Management's AMGN Position: Q2 2026 in Review
Provident Investment Management reduced its Amgen (AMGN) stake by 7% in Q2 2026, selling an estimated $147K and leaving 5,750 shares worth $2.08M. The position accounts for 0.2% of the portfolio, ranked #31.
Provident Investment Management first reported a position in AMGN in Q2 2013 and has held it in 33 quarters since. The position peaked at $2.44M in Q2 2018. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Provident Investment Management held 5,750 shares of Amgen worth $2.08M as of Q2 2026.
- Provident Investment Management sold 430 Amgen shares in Q2 2026, an estimated $147K.
- Amgen made up 0.2% of Provident Investment Management's portfolio in Q2 2026, its #31 holding.
- Provident Investment Management first reported a position in Amgen in Q2 2013 and has held it in 33 quarters since.
- Provident Investment Management's Amgen position peaked at $2.44M in Q2 2018.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Provident Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.